| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |